Craig A. Mullen, M.D., Ph.D.

Craig A. Mullen, M.D., Ph.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 777
Rochester, NY 14642

Office: (585) 275-2981
Fax: (585) 273-1039
Lab: (585) 275-1571

Professional Bio

Dr. Mullen serves as the Chief of the Pediatric Hematology / Oncology Division. He is also the Director the Fellowship Program. He has joint appointments as Professor in both the Department of Microbiology and Immunology and Professor in the Department of Oncology.

Research Bio

Dr. Mullen current research work examines the bone marrow microenvironment of acute lymphoblastic leukemia. The current goal of the work is to identify the molecular mechanisms by which nonmalignant cells in the marrow microenvironment that provide antiapoptotic support for leukemia cells. Ultimately this may identify new "drug-able" targets that may improve leukemia therapy.

Awards & Honors (Local)

Award for Second International Symposium on Minor Histocompatibility Antigens | International Congress of Histocompatibility and Immunogenetics 2002
Dean's Excellence Award | Graduate School of Biomedical Sciences | University of Texas-Houston Health Science Center 1999
American Association of Cancer Research | Upjohn Travel Award 1992
Alpha Omega Alpha 1986
Dr. Harold Lamport Biomedical Research Award (for the best PhD dissertation in biomedical research) | University of Chicago 1986
Phi Beta Kappa 1978

Recent Journal Articles

Showing the 5 most recent journal articles. 78 available »

Pahl, K.; Mullen, C.A. "Acute chest syndrome in sickle cell disease: Effect of genotype and asthma". Experimental Biology and Medicine. 2016; 241(7): 745-748. Link
Chen, J.; Mullen, C.A. "Patterns of diagnosis and misdiagnosis in pediatric cancer and relationship to survival". Journal of Pediatric Hematology and Oncology. 2016; .
Hsu YC, Mildenstein K, Hunter K, Tkachenko O, Mullen CA. "Acute lymphoid leukemia cells with greater stem cell antigen-1 (Ly6a/Sca-1) expression exhibit higher levels of metalloproteinase activity and are more aggressive in vivo." PloS one. 2014 9(2):e88966. Epub 2014 Feb 20.
2013 Apr
Oyeku SO, Driscoll MC, Cohen HW, Trachtman R, Pashankar F, Mullen C, Giardina PJ, Velazco N, Racine AD, Green NS. "Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease." Pediatric blood & cancer. 2013 Apr; 60(4):653-8. Epub 2012 Nov 05.
Green NS, Ender KL, Pashankar F, Driscoll C, Giardina PJ, Mullen CA, Clark LN, Manwani D, Crotty J, Kisselev S, Neville KA, Hoppe C, Barral S. "Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea." PloS one. 2013 8(2):e55709. Epub 2013 Feb 07.

Current Appointments

Professor - Department of Pediatrics, Hematology and Oncology (SMD) - Primary
Professor - Department of Microbiology and Immunology (SMD)
Professor - Cancer Center


Pediatrics - American Board of Pediatrics
Pediatric Hematology-Oncology - American Board of Pediatrics


MD | Medicine | University of Chicago - Pritzker School of Medicine1986
PhD | Pathology | University of Chicago1984
BS | Molecular Biology | University of Wisconsin1979

Post-Doctoral Training & Residency

Research in Immunohematology at National Institute of Health07/01/1992 - 6/30/94
Fellowship in Pediatric Hematology/Oncology at National Institute of Health07/01/1989 - 06/30/1992
Residency in Pediatrics at Children's Medical Center of Dallas07/01/1987 - 06/30/1989
Internship in Pediatrics at Children's Medical Center of Dallas07/01/1986 - 06/30/1987